When the Stryker Rejuvenate hip implant was introduced it was considered quite innovative in design; the Rejuvenate was marketed in 2009 after gaining FDA approval in June, 2008. While traditional hip implant designs were manufactured with a one piece neck and stem, both the Rejuvenate and ABGII have a design which implements a variety of components. In fact, the ABGII hip implant has sixteen stems—including left and right sides, and ten different sizes of modular neck. Six stems and sixteen necks make up the Rejuvenate hip implant system. Marketing for the Rejuvenate claimed that this hip implant was designed specifically for the younger, more active patient who was currently experiencing limited mobility of their hip joint.

The Stryker Rejuvenate hip implant was voluntarily recalled this past July following adverse reports and concerns with fretting and corrosion. Stryker had notified hospitals and physicians of the potential risks of the Rejuvenate in April.